CIMAZ, ROLANDO
 Distribuzione geografica
Continente #
NA - Nord America 24.008
EU - Europa 11.873
AS - Asia 4.698
SA - Sud America 750
OC - Oceania 275
AF - Africa 210
Continente sconosciuto - Info sul continente non disponibili 3
Totale 41.817
Nazione #
US - Stati Uniti d'America 23.895
RU - Federazione Russa 4.448
IE - Irlanda 1.673
HK - Hong Kong 1.629
PL - Polonia 1.576
SG - Singapore 1.564
SE - Svezia 1.342
IT - Italia 1.265
BR - Brasile 711
CN - Cina 696
FI - Finlandia 466
DE - Germania 305
AU - Australia 274
TR - Turchia 255
IN - India 242
GB - Regno Unito 231
FR - Francia 162
UA - Ucraina 160
CI - Costa d'Avorio 123
JO - Giordania 109
ES - Italia 89
CA - Canada 83
CH - Svizzera 55
VN - Vietnam 54
ID - Indonesia 39
NL - Olanda 32
IQ - Iraq 20
AT - Austria 18
BE - Belgio 17
SC - Seychelles 17
MA - Marocco 15
AR - Argentina 14
MX - Messico 14
BD - Bangladesh 12
EG - Egitto 11
AZ - Azerbaigian 9
IR - Iran 9
TN - Tunisia 9
ZA - Sudafrica 9
JP - Giappone 8
KR - Corea 8
KZ - Kazakistan 7
MU - Mauritius 7
BG - Bulgaria 6
EC - Ecuador 6
PK - Pakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
RO - Romania 5
CL - Cile 4
JM - Giamaica 4
LB - Libano 4
NO - Norvegia 4
BN - Brunei Darussalam 3
CO - Colombia 3
DZ - Algeria 3
KE - Kenya 3
LV - Lettonia 3
NG - Nigeria 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
CM - Camerun 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
RE - Reunion 2
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
IL - Israele 1
IM - Isola di Man 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 41.817
Città #
Santa Clara 4.225
Fairfield 3.160
Chandler 1.690
Dublin 1.672
Warsaw 1.572
Ashburn 1.427
Woodbridge 1.390
Cambridge 1.300
Seattle 1.264
Hong Kong 1.220
Houston 1.118
Wilmington 1.029
Singapore 815
Altamura 787
Lawrence 719
Princeton 645
Ann Arbor 450
Boston 390
Beijing 350
Jacksonville 337
Melbourne 262
Izmir 238
Boardman 215
Medford 214
Mumbai 189
San Diego 184
New York 141
Moscow 135
Abidjan 123
Falls Church 112
Florence 100
Buffalo 99
Barcelona 80
Norwalk 80
Shanghai 80
Paris 58
Toronto 56
The Dalles 54
Bern 52
Hillsboro 49
Los Angeles 49
Yubileyny 45
Andover 43
Jakarta 39
Dong Ket 38
Kent 37
Turku 37
London 36
Munich 33
Pune 33
São Paulo 33
Milan 30
Guangzhou 26
Rio de Janeiro 25
Philadelphia 23
Belo Horizonte 19
Vienna 18
Helsinki 17
Frankfurt Am Main 16
Phoenix 16
Brussels 15
Curitiba 15
Tappahannock 15
Brasília 14
Council Bluffs 14
Dearborn 14
Laurel 13
Chicago 12
Campinas 11
Frankfurt am Main 11
Porto Alegre 11
Redmond 11
San Mateo 11
Verona 11
Cairo 10
Kilburn 10
Baku 9
Rome 9
San Francisco 9
Baghdad 8
Bremen 8
Hefei 8
Nanjing 8
Palermo 8
Prato 8
Seoul 8
Serra 8
Shenzhen 8
Bari 7
Betim 7
Castelliri 7
Goiânia 7
Redwood City 7
Salvador 7
Sydney 7
Washington 7
Amman 6
Campo Grande 6
Chiswick 6
Dallas 6
Totale 29.071
Nome #
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 278
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 257
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 242
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 242
The intestinal microbiota in enthesitis-related arthitis 239
Managing pediatric osteoporosis 228
Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies 222
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 215
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 193
Anti-inflammatory and immunosuppressive drugs and reproduction. 191
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa 190
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 188
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 180
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). 178
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 176
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. 171
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 167
Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. 164
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 161
Kawasaki disease: an epidemiological study in central Italy 160
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 159
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 157
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 156
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 156
Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: Two case reports 156
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 154
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 154
Kawasaki disease in Sicily: clinical description and markers of disease severity. 152
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 152
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. 150
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 150
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting 150
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 150
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 149
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 147
Inflammatory morphea presenting as a hemifacial acquired port-wine stain 147
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 146
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 146
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 146
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 143
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 142
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone 141
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 137
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 135
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 134
Idiopathic congenital atrophoderma of Pasini and Pierini 132
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 131
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 131
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations. 130
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 130
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 130
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 129
Treating juvenile idiopathic arthritis to target: recommendations of an international task force 129
A 10-year follow-up of alendronate-treated young patients 128
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 127
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 124
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 124
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 124
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 123
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 123
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 122
Joint pain management in children and adolescents 121
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 121
Sex Differences in Pediatric Rheumatology 121
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 121
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 121
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 121
Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis 120
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 120
Sequential MR angiography in childhood primary angiitis of the CNS. 120
Clinical features and outcome of Cogan syndrome. 120
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 119
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 119
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 119
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 118
How advances in personalized medicine will change rheumatology 118
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 118
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. 118
Childhood uveitis 117
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 116
Serum amyloid-A in Behçet's disease. 116
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 116
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 116
Biological treatments in behçet's disease: Beyond anti-TNF therapy 115
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. 114
Cutaneous neonatal lupus: a case report and review of the literature. 114
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 114
Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. 113
Mucopolysaccharidoses. 112
Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients. 112
Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records 112
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene. 111
Distal extremity pain as a presenting feature of Fabry's disease. 111
How I treat juvenile idiopathic arthritis: A state of the art review 111
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. 111
Lupus, antiphospholipid syndrome and epilepsy: an update 111
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study. 110
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. 110
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 110
Totale 14.339
Categoria #
all - tutte 132.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 0 0 0 0 0 0 0 111
2020/20213.300 322 271 242 324 143 351 125 242 332 410 250 288
2021/20223.007 115 333 234 160 87 129 92 254 151 89 327 1.036
2022/20237.742 955 1.820 258 524 539 1.439 846 351 587 33 257 133
2023/20242.103 101 342 515 132 129 323 63 287 42 59 69 41
2024/202514.816 727 1.837 1.097 2.369 4.172 1.356 246 803 1.050 388 470 301
Totale 42.423